Skip to main content

Episode for Social Workers: Avoiding Roadblocks in Getting Your B-Cell Lymphoma Patients to CAR T-CELL Therapy

Click Here to Participate 

CE Activity Release Date: April 8, 2022
CE Activity Expiration Date: April 8, 2023 
Time to Complete Activity: 60 minutes
1.0 General Social Work continuing education credit


Target Audience

This CE activity is intended for social workers engaged in the care of patients with R/R B-cell lymphomas.



Mitigating roadblocks and opening the CAR(T) door to get your patients to therapy, this final episode is designed for social workers as a part of an educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes: Improving Access and Outcomes. This CE activity includes conversations among CAR-T experts and a community clinician; it includes patient video clips and numerous downloadable resources including a directory of CAR-T treatment centers organized by state. 

This activity focuses on managing logistics, improving access to CAR-T therapy for patients regardless of geography or socioeconomic status, numerous services offered by treating centers, how to overcome roadblocks for your patients including financial ones, and the need for earlier referral. 


Educational Objectives

After completing this CE activity, the participant should be better able to:

  • Recognize common misperceptions regarding logistics of CAR-T 
  • Refer patients for consultation to determine if they are candidates for CAR-T earlier in the treatment journey
  • Identify and use resources to address logistical challenges related to CAR-T



Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies
Attending Physician, Adult BMT Service 
Memorial Sloan Kettering Cancer Center
New York, NY

Sanjay K. Juneja, MD
Hematology, Medical Oncology
Chief of Oncology Line            
Baton Rouge General Hospital
Mary Bird Perkins Cancer Center
Baton Rouge, LA

Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX


Heather DiFilippo, MSN, CRNP 
Certified Adult Nurse Practitioner
University of Pennsylvania Health System
Philadelphia, PA
Misha Hawkins, MSN, RN, OCN 

Lead Cellular Therapy Coordinator 
The University of Texas MD Anderson Cancer Center
Houston, TX

Crissy Kus, BSN, RN
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society
Rye Brook, NY

Neena Kennedy, BSN, RN, OCN™
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society 
Rye Brook, NY

Alejandro Marinos-Velarde, MD
Hematology-Oncology Fellow
Baylor College of Medicine
Houston, TX

Elizabeth A. Weber, BSN, RN
Commercial Cellular Therapy Coordinator
University of Pennsylvania Health System
Philadelphia, PA

Educational Partner Statement & CME/CE Accreditation

This activity is developed with our educational partner, Medical Learning Institute, Inc.

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society.   Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Social workers completing this course receive 1.0 General Social Work continuing education credit.


Support Statement

This activity is supported by an independent educational grant from Bristol Myers Squibb.


Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. 


For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at